Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > just checking

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 23, 2023 2:05pm

212 Views

Post# 35356792

RE:just checking

No fireside chat needed.
We have all the information we need - for now.
Acute, Chronic and IBD are all in the funnel now.
So is the Antiviral but it isn't obvious ... yet.

$1.4 MM has been the monthly spend and it's exactly where it should be - to grow the funnel without breaking the bank. making anywhere from 1 to 4 points on the cash in the bank and we see other ways to cash too.

Watch the volume closely ... all of this up/down movement means nothing until we see >100K per day trading for about 4 weeks steady. Then we're back into P2 mode. Until then ... it's random.

Good luck !!!!

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide